Chapter CE events

Jessica Power, B.Sc.(Pharm.), ACPR Experiential Education Facilitator and Clinical Pharmacist, Victoria General Hospital This presentation will be an introduction to EEF role, a discussion of novel precepting models, as well as strategies to face inherent challenges. We will look at OEE changes to rotations including

This presentation will be an introduction to EEF role, a discussion of novel precepting models, as well as strategies to face inherent challenges. We will look at OEE changes to rotations including description of the new IPPE II PHRM 272 rotation activities and work through three difficult student situations.

This presentation will be a review of two complex aspects of chronic kidney disease: bone mineral metabolism and anemia of chronic kidney disease. Pathophysiology, pharmacotherapy, monitoring parameters, and clinical pearls will be reviewed.

Arden Barry, BSc, BSc(Pharm), PharmD, ACPR Clinical Pharmacy and Research Specialist, Lower Mainland Pharmacy Services; Assistant Professor (Partner), Faculty of Pharmaceutical Sciences, University of British Columbia; Associate Member, Department of Family Practice, Faculty of Medicine, University of British Columbia

The treatment of dyslipidemia is controversial despite a plethora of available published evidence. This has led to the development of multiple dyslipidemia guidelines— while these documents differ with respect philosophy and complexity, they are more similar than they are different. This presentation aims to explore three recently published dyslipidemia guidelines with the goal of deriving a few pragmatic considerations that participants can apply in practice.